Laparoscopic bariatric surgery is safe during phase 2-3 of COVID-19 pandemic in Italy: A multicenter, prospective, observational study.

ABSTRACT:

Background

Sars-Cov-2 epidemic in Italy caused one of the greatest 2020 European outbreaks, with suspension of elective bariatric/metabolic surgery (BMS). From May 2020 a significant decline of the epidemic has been observed (phase 2); National Health Service protocols permitted elective BMS' resumption. A new, more severe COVID-19 surge, the "second wave", started on October 2020 (phase 3).

Aim

The primary end point was to analyze the outcomes of any Sars-Cov-2 infection and related morbidity/mortality within 30 POD after laparoscopic BMS during phase 2-3; secondary end points were readmission and reoperation rates.

Methods

Study design prospective, multicenter, observational.

Setting

Eight Italian high-volume bariatric centers. All patients undergoing BMS fro

SUBMITTER: Silecchia G 

PROVIDER: S-EPMC8200253 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature